Reported by CommitteeFiled Jan 23, 2026
Sponsor: Joint Committee on Financial Services
Latest Action
House: Reporting date extended to Thursday, December 31, 2026
Jul 9, 2026
Summary
This legislation concerns the regulation or availability of epinephrine injectors, devices used to treat severe allergic reactions. It would affect individuals who may need the devices, as well as schools, healthcare providers, and other entities that handle them. The measure aims to improve public health safety regarding allergic emergencies.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when H 4943 changes status, plus AI-powered summaries and stage predictions.
Sign up free